Early interventions for substance-using adolescents show promise

shutterstock_71234929

Substance misuse has been a bit of a theme on the Mental Elf this week and I’m continuing with that today, firstly with this piece from the Lifestyle Elf.  Don’t forget, if you’re interested in healthy lifestyle issues (exercise, obesity, quitting smoking, alcohol, substance misuse), you should be following the excellent Lifestyle Elf blog. Earlier [read the full story…]

Preventing children of substance-affected parents from becoming users

shutterstock_64914907

Prevention is better than cure, right? When it comes to preventing drug- and alcohol-misuse, children of substance-abusing parents are a really important group to work with, as they are at higher risk of developing their own subtance-related problems, or other mental health problems, than their peers from non-substance-using families. My cousin the Lifestyle Elf has highlighted a [read the full story…]

Can hypnosis help prevent postnatal depression?

shutterstock_29258065

The short answer is we don’t know, but trials are underway that might help answer this question. Postnatal depression often affects women in the first 3 months after giving birth and symptoms can range from low mood and loss of interest in daily activities to thoughts of suicide. There are a range of effective treatments [read the full story…]

Omega-3 fish oil supplements don’t help with cognitive decline or dementia in the short-term, according to new Cochrane review

shutterstock_55385059

Fish oil supplements are big business. The worldwide omega-3 market has recently been valued at around $5 billion with 40% growth predicted between 2010 and 2015. Omega-3 fatty acids are fats responsible for many important jobs in the body. We get these fats through our daily diets and the three major omega-3 fats are: Alpha [read the full story…]

Extrapyramidal side effects from second-generation antipsychotic drugs: new systematic review

shutterstock_45290365

The newer second-generation antipsychotic drugs (Risperidone, Quetiapine, Amisulpride, Aripiprazole, Clozapine, Olanzapine) are promoted because they have a lower risk of extrapyramidal side effects than older drugs. Drug companies often promote these newer drugs as virtually free from extrapyramidal side effects, but the patients who take them and the clinicians who prescribe them often don’t agree. [read the full story…]

Here is the evidence for exercising if you are depressed

shutterstock_42861211

Ooh, what a palaver over the depression and exercise story!  Such a lot of words have been written about the study published in the BMJ last week, including by me. The study itself was well conducted but frankly disappointing (for us readers and the researchers themselves), finding as it did that a specific treatment to [read the full story…]

Secretin should not be used to treat autism spectrum disorders

shutterstock_3347646

In 1998 a very small study was published, involving just 3 children with autism, who were treated with a hormone called secretin that controls digestion. Here’s the abstract of the study by Horvath et al: We report three children with autistic spectrum disorders who underwent upper gastrointestinal endoscopy and intravenous administration of secretin to stimulate [read the full story…]

The evidence remains weak for using CBT to help children who have suffered sexual abuse

shutterstock_14792530

Child sexual abuse is a widespread social problem, which can cause a range of mental health conditions including fear, anxiety, post-traumatic stress disorder, behavioural problems, inappropriate sexual behaviour and an increased risk of psychological problems in adulthood. Cognitive behavioural therapy is often used to help children (and their non-offending parent) to manage the conditions that [read the full story…]

Why is it so difficult to measure the prevalence of depression in people aged 75 and over?

shutterstock_30332995

A number of reviews have been published in recent years, which explore the prevalence of depression in old people. Prevalence rates vary enormously from one study to the next and so the reviews tend to report quite a wide range, typically up to 10%. Prevalence is defined as: “a measure of the proportion of people [read the full story…]

Mobile crisis teams reduce hospital admissions for serious mental illness, according to updated Cochrane review

shutterstock_58203940

‘Crisis intervention’ and ‘home-care packages’ are provided in the community to help people who are going through an acute phase of severe mental illness. The Cochrane Schizophrenia Group have updated their review on this topic by conducting their usual robust and systematic search for randomised controlled trials of crisis intervention models versus standard care for [read the full story…]